Chemotherapy-Induced Cognitive Impairment (CICI): Pathophysiological Mechanisms and the Rationale for Investigating Ozone Therapy
Antioxidants · 16.11.2026 · 15 (11) · 1480
DOI: 10.3390/antiox15111480 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 16.11.2026. Verfasst von Bernardino Clavo und 13 weiteren Autor:innen. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cabildo de Gran Canaria.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Chemotherapy-induced cognitive impairment (CICI) is an increasingly recognized complication of cancer treatment, particularly among breast cancer survivors, characterized by persistent difficulties in memory, attention, executive function, and processing speed. This review summarizes current evidence on the clinical phenotype and biological mechanisms of CICI and examines the rationale for investigating medical ozone as a redox-modulating intervention. A translational narrative review was conducted using literature published between 2000 and September 2026, retrieved from PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar, complemented by manual reference-list screening. Clinical, preclinical, mechanistic, and evidence-synthesis studies were examined to critically assess the pathophysiology of CICI and the biological rationale for investigating ozone-induced redox modulation. Current evidence points to a multifactorial pathophysiology of CICI and provides a rationale for testing whether controlled redox modulation can influence some of the pathways involved, including activation of endogenous antioxidant and adaptive pathways. Preliminary evidence from chemotherapy-induced peripheral neuropathy and selected neurological or cognitive conditions provides indirect translational support, but does not establish efficacy in CICI. Medical ozone should therefore be considered investigational in this context. The hypothesis should be tested in randomized, sham-controlled trials using validated cognitive outcomes, mechanistic biomarkers, and appropriate oncological safety monitoring to determine whether ozone-induced redox adaptation can produce clinically meaningful cognitive benefit.
Förderung
- Cabildo de Gran Canaria
Zitieren
APA
Clavo, B., Martínez-Sánchez, G., Cazorla-Rivero, S. E., Cánovas-Molina, Á., Román-Liñán, J. C., Cobiella-Hernández, L., Ramos-Vega, S., Pérez-Santana, C. G., Díaz-Garrido, J. A., Federico, M., Guardamagna, M., Martínez-Pérez, R., Morales-Alamo, D., & Rodríguez-Esparragón, F. (2026). Chemotherapy-Induced Cognitive Impairment (CICI): Pathophysiological Mechanisms and the Rationale for Investigating Ozone Therapy. Antioxidants, 15(11), 1480. https://doi.org/10.3390/antiox15111480
Vancouver
Clavo B, Martínez-Sánchez G, Cazorla-Rivero SE, Cánovas-Molina Á, Román-Liñán JC, Cobiella-Hernández L, et al. Chemotherapy-Induced Cognitive Impairment (CICI): Pathophysiological Mechanisms and the Rationale for Investigating Ozone Therapy. Antioxidants. 2026;15(11):1480. doi:10.3390/antiox15111480
BibTeX
@article{Clavo2026,
author = {Clavo, Bernardino and Martínez-Sánchez, Gregorio and Cazorla-Rivero, Sara E. and Cánovas-Molina, Ángeles and Román-Liñán, José C. and Cobiella-Hernández, Luis and Ramos-Vega, Sara and Pérez-Santana, Carmen G. and Díaz-Garrido, Juan A. and Federico, Mario and Guardamagna, Mora and Martínez-Pérez, Rocío and Morales-Alamo, David and Rodríguez-Esparragón, Francisco},
title = {Chemotherapy-Induced Cognitive Impairment (CICI): Pathophysiological Mechanisms and the Rationale for Investigating Ozone Therapy},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {11},
pages = {1480},
doi = {10.3390/antiox15111480}
}
EUVIMED